MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failure von Dreicer, R., Stadler, W. M., Ahmann, F. R., Whiteside, T., Bizouarne, N., Acres, B., Limacher, J.-M., Squiban, P., Pantuck, A.

Volltext

Gene-Based Vaccines and Immunotherapeutics von Liu, Margaret, Acres, Bruce, Balloul, Jean-Marc, Bizouarne, Nadine, Paul, Stephane, Slos, Philippe, Squiban, Patrick

Volltext

Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer von Rochlitz, Christoph, Figlin, Robert, Squiban, Patrick, Salzberg, Marc, Pless, Miklos, Herrmann, Richard, Tartour, Eric, Zhao, Yongxiang, Bizouarne, Nadine, Baudin, Martine, Acres, Bruce

Volltext

Selective induction of peripheral and mucosal endothelial cell addressins with peripheral lymph nodes and Peyer's patch cell-conditioned media von Denis, Véronique, Dupuis, Philippe, Bizouarne, Nadine, Sampaio, Silvia de O., Hong, Li, Lebret, Marilyne, Monsigny, Michel, Nakache, Maurice, Kieda, Claudine

Volltext

Biomarkers associated with clinical outcome in advanced non-small cell lung cancer patients treated with TG4010 von Acres, B., Quoix, E., Ramlau, R., Lacoste, G., Marie Bastien, B., Tavernaro, A., Bettinger, S., Bizouarne, N., Limacher, J. M., Bonnefoy, J. Y.

Volltext

Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer von SCHOLL, Susy M, BALLOUL, Jean-Marc, FRIDMAN, Wolf, POUILLART, Pierre, ACRES, Bruce, LE GOC, Gwenaelle, BIZOUARNE, Nadine, SCHATZ, Christian, KIENY, Marie Paule, VON MENSDORFF-POUILLY, Sylvia, VINCENT-SALOMON, Anne, DENEUX, Laurent, TARTOUR, Eric

Volltext

Breast cancer immunotherapy: Preclinical study of a recombinant vaccinia virus vector expressing Muc1 and IL2 von Bizouarne, N

Volltext

MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines von ACRES, B, APOSTOLOPOULOS, V, BALLOUL, J.-M, WRESCHNER, D, XING, P.-X, ALI-HADJI, D, BIZOUARNE, N, KIENY, M. P, MCKENZIE, I. F. C

Volltext

Metastatic Breast Tumour Regression Following Treatment by a Gene-Modified Vaccinia Virus Expressing MUC1 and IL-2 von Scholl, Susy, Squiban, Patrick, Bizouarne, Nadine, Baudin, Martine, Acres, Bruce, Von Mensdorff-Pouilly, Silvia, Shearer, Moira, Beuzeboc, Philippe, Van Belle, S., Uzielly, B., Pouillart, Pierre, Taylor-Papadimitriou, Joyce, Miles, David

Volltext

Vaccine immunotherapy with MVA-Muc1-IL2 (TG4010) in prostate cancer patients with biochemical failure von Dreicer, R., Ahman, R., Pantuck, A., Stadler, W. M., Bizouarne, N., Acres, B., Derbij, A., Limacher, J.-M., Squiban, P.

Volltext

MVA-MUC1-IL2 vaccine immunotherapy for advanced non small cell lung cancer (NSCLC) : Interim phase II data von Squiban, P., Velu, T., Mennecier, B., Pless, M., Morel, V., Levy, E., Richard, V., Maciejewska, T., Bizouarne, N., Quoix, E.

Volltext

MVA-MUC1-IL2 vaccine immunotherapy for advanced non small cell lung cancer (NSCLC) : Interim phase II data von Squiban, P., Velu, T., Mennecier, B., Pless, M., Morel, V., Levy, E., Richard, V., Maciejewska, T., Bizouarne, N., Quoix, E.

Volltext

A phase II study evaluating the clinical efficacy of TG4010 (MVA-MUC1-IL2) in association with chemotherapy in patients with non small cell lung cancer von Velu, T., Ramlau, R., Quoix, E., Pawlicki, M., Pless, M., Lena, H., Lévy, E., Krzakowski, M., Limacher, J.-M., Bizouarne, N.

Volltext

Targeted macrophage cytotoxicity using a nonreplicative live vector expressing a tumor-specific single-chain variable region fragment von PAUL, S, SNARY, D, BURCHELL, J, TAYLOR-PAPADIMITRIOU, J, ACRES, R. B, HOEBEKE, J, ALLEN, D, BALLOUL, J.-M, BIZOUARNE, N, DOTT, K, GEIST, M, HILGERS, J, KIENY, M. P

Volltext

Redirected cellular cytotoxicity by infection of effector cells with a recombinant vaccinia virus encoding a tumor-specific monoclonal antibody von Paul, S, Bizouarne, N, Dott, K, Ruet, L, Dufour, P, Acres, R B, Kieny, M P

Volltext

Specific immunotherapy of MUC1-positive adenocarcinomas with a recombinant vaccinia virus expressing MUC1 and IL-2 von Bizouarne, N, Squiban, P, Acres, B, Balloul, JM, Ohresser, MA, Figlin, R, Belldegrun, A, Herrman, R, Rochlitz, C

Volltext

Lack of evidence for an immunosuppressive role for MUC1 von PAUL, S, BIZOUARNE, N, PAUL, A, PRICE, M. R, HANSSON, G. C, KIENY, M. P, ACRES, R. B

Volltext

255 MVA-MUC1-IL2 vaccine immunotherapy for advanced non-small cell lung cancer (NSCLC): interim phase II data von Faivre-Bizouarne, N., Velu, T., Mennecier, B., Pless, M., Morel, V., Levy, E., Richard, V., Limacher, J.M., Squiban, P., Quoix, E.

Volltext

A SV-40 immortalized murine endothelial cell line from peripheral lymph node high endothelium expresses a new α-L-fucose binding protein von Bizourne, Nadine, Denis, Véronique, Legrand, Alain, Monsigny, Michel, Kieda, Claudine

Volltext

Characterization of membrane sugar-specific receptors in cultured high endothelial cells from mouse peripheral lymph nodes von Bizourane, Nadine, Mitterrand, Michèle, Monsigny, Michel, Kieda, Claudine

Volltext